Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellularised vs Uncellularised LG002 for Severe Burn Injury
NCT00366041Phase 2Terminated
- Sponsor
- Laboratoires Genevrier
- Start
- Feb 2006
- Primary completion
- Dec 2008
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of LG002 in burn injury, sponsored by Laboratoires Genevrier. Started Feb 2006; status: terminated.
02
Drugs
LG002
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00366041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366041.